C.R. Bard News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.11.15	C. R. Bard To Buy Liberator Medical Holdings - Quick Facts (RTTNews)
22.10.15	C.R. Bard Inc Reveals 5% Advance In Q3 Profit (RTTNews)
30.09.15	C.R. Bard To Buy Full Ownership Of Its JV In Japan - Quick Facts (RTTNews)
03.08.15	C. R. Bard Gets Approval For IP Reimbursement For Lutonix Drug-Coated Balloon (RTTNews)
23.07.15	C. R. Bard Q2 Profit Tops Estimates - Quick Facts (RTTNews)
23.07.15	EARNINGS SUMMARY: Details of C.R. Bard Inc Q2 Earnings Report (RTTNews)
25.06.15	C. R. Bard: Clinical Data Reinforces Superior Results For Lutonix 035 DCB (RTTNews)
10.06.15	C.R. Bard Authorizes $500 Mln Share Buyback (RTTNews)
24.04.15	C. R. Bard Q1 Profit Down (RTTNews)
13.02.15	C.R. Bard, Inc. -- Moody's downgrades C.R. Bard's long term rating to Baa1 from A3; outlook stable (Moodys)
29.01.15	C. R. Bard Reports Q4 Adj. EPS Of $2.29 - Quick Facts (RTTNews)
22.10.14	C. R. Bard Q3 Profit Rises - Quick Facts (RTTNews)
11.06.14	Bard Announces $500 Miln Stock Buyback Authorization; Boosts Dividend (RTTNews)
22.04.14	C. R. Bard Q1 Profit Rises - Quick Facts (RTTNews)
31.01.14	Bard Announces New $500 Mln Stock Buyback Authorization (RTTNews)
30.01.14	C. R. Bard Q4 Profit Rises - Quick Facts (RTTNews)
22.10.13	C. R. Bard Q3 Adj. Profit Declines; Yet Tops View - Quick Facts (RTTNews)
09.09.13	Appointments, Successful Clinical Trials, Mergers, and New Contracts Boost Growth - Research Report on BioMarin, ARIAD, Bard, Rockwell Medical, and Health Net (PR Newswire)
05.09.13	Acquisition of Rochester Medical Corporation by C. R. Bard, Inc. May Not Be in the Best Interests of Rochester Medical Corporation Shareholders (PR Newswire)
04.09.13	C. R. Bard To Buy Rochester Medical For About $262 Mln (RTTNews)
03.09.13	Investors Conferences and FDA-Approved Products - Research Report on Baxter International, CR Bard, BD, Cooper, and Thoratec (PR Newswire)
19.08.13	Bard To Buy Privately-held Medafor For $200 Mln - Quick Facts (RTTNews)
01.08.13	FDA Approvals, Dividends, New Technologies, and Solid Margins Increase Shareholder Value - Research Report on Abbott, Baxter, CareFusion, Haemonetics, and CR Bard (PR Newswire)
01.08.13	C.R. Bard, Inc. -- Moody's changes C.R. Bard's outlook to negative from stable; affirms A3 rating (Moodys)
26.07.13	Earnings Releases, Investment Plans, Commencement of Clinical Trials, and FDA Applications Brighten Outlook - Research Report on Bard, Centene, Exact Sciences, Ironwood, and Merrimack (PR Newswire)
23.07.13	C. R. Bard Posts Q2 Loss On Charges - Quick Facts (RTTNews)
23.07.13	Quarterly Dividends, Invitations to Conference Calls, Completion of Acquisitions, and Certifications for Healthcare Products - Research Report on Covidien, Bard, Mindray, CareFusion, and DENTSPLY (PR Newswire)
11.06.10	WALL STREET NACHBÖRSE/National Semiconductor legen zu (Dow Jones)
13.04.09	Bard Promotes Jim C. Beasley to Group Vice President (Businesswire)
10.12.08	Bard Declares Quarterly Dividend (Businesswire)
06.06.08	Bard Closes Transaction to Acquire Specialized Health Products International, Inc. (Businesswire)
31.01.08	Bard Announces Fourth Quarter Results (Businesswire)
23.10.07	Bard Announces Third Quarter Results (Businesswire)
24.04.07	Bard Announces First Quarter Results (Businesswire)
12.01.05	Bard Acquires Certain Assets of Genyx Medical (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

14.01.25		Aufschläge in New York: S&P 500 verbucht letztendlich Gewinne
14.01.25		Starker Wochentag in New York: S&P 500 am Nachmittag mit Zuschlägen
14.01.25		Börse New York in Rot: So entwickelt sich der S&P 500 mittags
08.01.25		S&P 500-Handel aktuell: S&P 500 präsentiert sich zum Handelsende fester
08.01.25		Verluste in New York: S&P 500 präsentiert sich leichter
08.01.25		Zuversicht in New York: Am Mittwochmittag Gewinne im S&P 500

14.01.25

Aufschläge in New York: S&P 500 verbucht letztendlich Gewinne

14.01.25

Starker Wochentag in New York: S&P 500 am Nachmittag mit Zuschlägen

14.01.25

Börse New York in Rot: So entwickelt sich der S&P 500 mittags

08.01.25

S&P 500-Handel aktuell: S&P 500 präsentiert sich zum Handelsende fester

08.01.25

Verluste in New York: S&P 500 präsentiert sich leichter

08.01.25

Zuversicht in New York: Am Mittwochmittag Gewinne im S&P 500

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Novartis	95.58	1.90 %	K V
Logitech Intl	91.48	1.35 %	K V
Part Grp Hldg	1’393.00	1.20 %	K V
Roche Hldg G	286.00	0.28 %	K V
Sonova Hldg	319.20	0.16 %	K V
Swiss Re	139.40	-0.50 %	K V
Zurich Insur Gr	553.80	-0.54 %	K V
Kuehne+Nagel Int	207.60	-0.76 %	K V
Lonza Grp	582.00	-1.49 %	K V
Nestle	77.48	-1.53 %	K V

Nachrichten zu C.R. Bard Inc.

Aktien Top/Flop

C.R. Bard Peer Group Nachrichten

Meistgelesene Nachrichten